ClinicalTrials.gg
CompletedNCT07926178Updated Nov 9, 2026

3D Versus Low-Temperature Thermoplastic Relative Motion Orthosis: MP Joint Stabilization

An interventional study of 3D-Printed TPU Relative Motion Flexion Orthosis and 3D-Printed PLA Relative Motion Flexion Orthosis in Relative Motion Flexion Orthosis Evaluation, sponsored by Enver Guven. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Enver Guven · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 2 years 4 months after the study started (first participant enrolled Jun 2024, registered Nov 2026).
Updated Nov 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Relative motion flexion (RMF) orthoses are used in hand rehabilitation to position finger joints in a controlled degree of flexion. These orthoses are traditionally made from low-temperature thermoplastic materials. Three-dimensional (3D) printing offers an alternative method of producing individually designed orthoses using different filament materials.

The purpose of this study was to compare finger joint stabilization and user satisfaction among RMF orthoses made from two 3D-printing materials, thermoplastic polyurethane (TPU) and polylactic acid (PLA), and a conventional low-temperature thermoplastic (LTT) material.

The study included 30 healthy adult volunteers. Each participant used all three types of RMF orthoses for two consecutive days per orthosis, with the order of application randomly determined. The orthoses were designed to position the metacarpophalangeal (MCP) joint at 30 degrees of flexion.

Joint positioning was evaluated using a goniometer, and user satisfaction was assessed using the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0).

The study aimed to provide comparative information about orthosis materials and fabrication methods that may help guide future orthotic applications in hand rehabilitation.

02

Conditions studied

  • Relative Motion Flexion Orthosis Evaluation

Keywords

  • Relative Motion Flexion Orthosis
  • 3D Printing
  • Thermoplastic Polyurethane (TPU)
  • Polylactic Acid (PLA)
  • Low-Temperature Thermoplastic (LTT)
  • Metacarpophalangeal Joint Stabilization
  • User Satisfaction
  • QUEST 2.0
03

In context

Lead sponsor

Enver Guven is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy adult volunteers.
  • No orthopedic or neurological impairments involving the upper extremities.
  • No reported history of systemic illness or previous surgical interventions.
  • Provision of written before enrollment.

Exclusion criteria

Exclusion Criteria:

  • Current upper extremity pain.
  • Joint deformities.
  • Skin integrity problems.
  • Any condition that could interfere with RMF orthosis application or wearing.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    TPU-PLA-LTT

    Participants received three RMF orthoses in the following order: 3D-printed TPU, 3D-printed PLA, and conventional LTT. Each orthosis was worn for two consecutive days.

    Device: 3D-Printed TPU Relative Motion Flexion Orthosis · Device: 3D-Printed PLA Relative Motion Flexion Orthosis · Device: Low-Temperature Thermoplastic Relative Motion Flexion Orthosis

  • Experimental
    TPU-LTT-PLA

    Participants received three RMF orthoses in the following order: 3D-printed TPU, conventional LTT, and 3D-printed PLA. Each orthosis was worn for two consecutive days.

    Device: 3D-Printed TPU Relative Motion Flexion Orthosis · Device: 3D-Printed PLA Relative Motion Flexion Orthosis · Device: Low-Temperature Thermoplastic Relative Motion Flexion Orthosis

  • Experimental
    PLA-TPU-LTT

    Participants received three RMF orthoses in the following order: 3D-printed PLA, 3D-printed TPU, and conventional LTT. Each orthosis was worn for two consecutive days. Açıklamayı kopyala

    Device: 3D-Printed TPU Relative Motion Flexion Orthosis · Device: 3D-Printed PLA Relative Motion Flexion Orthosis · Device: Low-Temperature Thermoplastic Relative Motion Flexion Orthosis

  • Experimental
    PLA-LTT-TPU

    Participants received three RMF orthoses in the following order: 3D-printed PLA, conventional LTT, and 3D-printed TPU. Each orthosis was worn for two consecutive days.

    Device: 3D-Printed TPU Relative Motion Flexion Orthosis · Device: 3D-Printed PLA Relative Motion Flexion Orthosis · Device: Low-Temperature Thermoplastic Relative Motion Flexion Orthosis

  • Experimental
    LTT-TPU-PLA

    Participants received three RMF orthoses in the following order: conventional LTT, 3D-printed TPU, and 3D-printed PLA. Each orthosis was worn for two consecutive days.

    Device: 3D-Printed TPU Relative Motion Flexion Orthosis · Device: 3D-Printed PLA Relative Motion Flexion Orthosis · Device: Low-Temperature Thermoplastic Relative Motion Flexion Orthosis

  • Experimental
    LTT-PLA-TPU

    Participants received three RMF orthoses in the following order: conventional LTT, 3D-printed PLA, and 3D-printed TPU. Each orthosis was worn for two consecutive days. Açıklamayı kopyala

    Device: 3D-Printed TPU Relative Motion Flexion Orthosis · Device: 3D-Printed PLA Relative Motion Flexion Orthosis · Device: Low-Temperature Thermoplastic Relative Motion Flexion Orthosis

Interventions

  • Device3D-Printed TPU Relative Motion Flexion Orthosis

    A custom relative motion flexion orthosis fabricated using thermoplastic polyurethane (TPU) filament. Individual hand geometry was obtained by 3D scanning, and the orthosis was digitally designed using Meshmixer software and manufactured using a Creality CR-10 Max 3D printer. The orthosis positioned the third metacarpophalangeal joint at 30 degrees of flexion and was worn for two consecutive days. Açıklamayı kopyala

  • Device3D-Printed PLA Relative Motion Flexion Orthosis

    A custom relative motion flexion orthosis fabricated using polylactic acid (PLA) filament. Individual hand geometry was obtained by 3D scanning, and the orthosis was digitally designed using Meshmixer software and manufactured using a Creality CR-10 Max 3D printer. The orthosis positioned the third metacarpophalangeal joint at 30 degrees of flexion and was worn for two consecutive days.

  • DeviceLow-Temperature Thermoplastic Relative Motion Flexion Orthosis

    A conventional relative motion flexion orthosis fabricated using Orficast More low-temperature thermoplastic material (Orfit Industries, Belgium). The orthosis was manually molded directly on the participant's hand, positioning the third metacarpophalangeal joint at 30 degrees of flexion, verified using a goniometer. The orthosis was worn for two consecutive days.

06

What researchers measure

Primary outcomes

  1. MCP Joint Stabilization

    The metacarpophalangeal (MCP) joint angle of the third digit of the dominant hand was measured in degrees using a goniometer after each orthosis wearing period. All orthoses were designed to maintain the MCP joint at 30 degrees of flexion. The measured joint angles were compared among three relative motion flexion (RMF) orthoses fabricated from 3D-printed thermoplastic polyurethane (TPU), 3D-printed polylactic acid (PLA), and conventional low-temperature thermoplastic (LTT). Values closer to 30 degrees indicated more accurate maintenance of the target joint position.

    Time frame: At the end of each 2-day orthosis wearing period (3 assessments per participant).

Secondary outcomes

  1. QUEST 2.0 Total Satisfaction Score

    Overall user satisfaction was assessed using the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0). The questionnaire includes 12 items covering device-related satisfaction (8 items) and service-related satisfaction (4 items). Each item is rated on a 5-point Likert scale, with higher scores indicating greater satisfaction. Total satisfaction scores were compared across TPU, PLA, and LTT orthoses.

    Time frame: At the end of each 2-day orthosis wearing period (3 assessments per participant).

  2. QUEST 2.0 Device Satisfaction Score

    Device-related satisfaction was assessed using the eight device items of the QUEST 2.0 questionnaire: dimensions, weight, adjustability, safety, durability, ease of use, comfort, and effectiveness. Each item is rated on a 5-point Likert scale, with higher scores indicating greater satisfaction. Device satisfaction scores were compared among TPU, PLA, and LTT orthoses.

    Time frame: At the end of each 2-day orthosis wearing period (3 assessments per participant).

  3. QUEST 2.0 Service Satisfaction Score

    Service-related satisfaction was assessed using the four service items of the QUEST 2.0 questionnaire, covering maintenance, repair, professional services, and follow-up. Each item is rated on a 5-point Likert scale, with higher scores indicating greater satisfaction. Service satisfaction scores were compared among TPU, PLA, and LTT orthoses.

    Time frame: At the end of each 2-day orthosis wearing period (3 assessments per participant).

07

Study locations

1 site
  • Ankara University, Faculty of Health Sciences
    Ankara, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2024 to primary completion in Feb 2025, 8 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 3, 2026
First posted
Nov 9, 2026
StartActual
Jun 12, 2024
Primary completionActual
Feb 21, 2025
CompletionActual
Feb 27, 2025
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07926178
Lead sponsor
Enver Guven
Responsible party
Enver Guven (Assistant Professor, Ankara University) — Sponsor-investigator
First posted
Nov 9, 2026
Start date
Jun 12, 2024
Primary completion
Feb 21, 2025
Completion
Feb 27, 2025
Last update
Nov 9, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion